Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Biallelic variants in NDUFA13 have been associated with mitochondrial complex I deficiency, nuclear type 28, a moderate-to-severe neurodevelopmental disorder presenting in early childhood. In a cohort of 13 affected individuals from 11 unrelated families, patients exhibited oculomotor abnormalities (84%), spasticity/hypertonia (83%), hypotonia (69%), cerebellar ataxia (66%), movement disorders (58%) and seizures (46%) (PMID:39963288). Neuroimaging consistently revealed bilateral symmetric T2 hyperintense substantia nigra lesions and optic nerve atrophy.
Genetic evidence supports autosomal recessive inheritance. Four missense variants—including the recurrent c.170G>A (p.Arg57Gln)—and three ultra-rare predicted loss-of-function variants were identified in trans in all probands, with segregation confirmed in two families having multiple affected siblings (PMID:39963288).
Functional studies demonstrate that patient fibroblasts harboring NDUFA13 variants have markedly reduced complex I enzymatic activity and compensatory complex IV upregulation. Protein structural modeling indicates that missense substitutions destabilize a critical junction between the hydrophilic and membrane arms of complex I, impairing assembly and electron transfer (PMID:39963288).
GRIM-19 (NDUFA13) loss-of-function underlies disease pathogenesis via impaired complex I assembly and mitochondrial membrane potential collapse. Independent deletion and truncation analyses in cell models confirm that disruption of GRIM-19 abrogates membrane potential maintenance, sensitizing cells to apoptotic stimuli (PMID:18287540).
No conflicting reports have been documented to date, and the phenotypic and molecular findings are highly concordant across all studied families. Together, the genetic and experimental data robustly support a pathogenic role for biallelic NDUFA13 variants in mitochondrial complex I deficiency, nuclear type 28.
Key take-home: Biallelic NDUFA13 variants cause a distinct early-onset neurodevelopmental syndrome through loss of complex I function, establishing diagnostic and potential therapeutic avenues.
Gene–Disease AssociationStrong13 probands across 11 families, multi-family segregation, concordant functional data Genetic EvidenceStrong13 biallelic variants in trans in 13 probands; segregation in two multiplex families; recurrent c.170G>A observed Functional EvidenceModeratePatient fibroblasts show reduced complex I activity and compensatory complex IV increase; protein modeling and deletion constructs confirm essential role in membrane potential |